WordNet
- an electrical phenomenon whereby an electromotive force (EMF) is generated in a closed circuit by a change in the flow of current (同)inductance
- the act of bringing about something (especially at an early time); "the induction of an anesthetic state"
- (law) the act of remitting (especially the referral of a law case to another court) (同)remitment, remit
- an abatement in intensity or degree (as in the manifestations of a disease); "his cancer is in remission" (同)remittal, subsidence
PrepTutorEJDIC
- 〈C〉《米》募兵 / 〈C〉(聖職・公職などへの)就任,就任式 / 〈U〉〈C〉(…を)引き起こすこと《+『to』+『名』》 / 〈U〉(電気の)誘導 / 〈U〉〈C〉(論理学・数学で)帰納,帰納法
- 〈U〉(罪からの)赦免《+『from』+『名』》 / 〈U〉〈C〉(借金・義務からの)免除《+『of』+『名』》 / 〈U〉(苦痛・病気などの一時的な)軽減,和らぎ
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 若年成人における急性骨髄性白血病に対する導入療法 induction therapy for acute myeloid leukemia in younger adults
- 2. 成人におけるフィラデルフィア染色体陽性急性リンパ芽球性白血病に対する導入療法 induction therapy for philadelphia chromosome positive acute lymphoblastic leukemia in adults
- 3. 成人におけるフィラデルフィア染色体陰性急性リンパ芽球性白血病に対する導入療法 induction therapy for philadelphia chromosome negative acute lymphoblastic leukemia in adults
- 4. 高齢者における急性骨髄性白血病の治療 treatment of acute myeloid leukemia in older adults
- 5. 成人における急性前骨髄球性白血病の初期治療 initial treatment of acute promyelocytic leukemia in adults
English Journal
- Innovative cell therapy in the treatment of serious adverse events related to both chemo-radiotherapy protocol and acute myeloid leukemia syndrome: the infusion of mesenchymal stem cells post-treatment reduces hematopoietic toxicity and promotes hematopoietic reconstitution.
- Fouillard L, Francois S, Bouchet S, Bensidhoum M, Elm'selmi A, Chapel A1.Author information 1Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Laboratoire de Radiopathologie et de Thérapie Expérimentale, BP 17, 92262 Fontenay- aux-Roses, France. alain.chapel@irsn.fr.AbstractBone marrow stroma is damaged by chemotherapy and irradiation protocol. Bone marrow microenvironment supports haematopoiesis and comprises Mesenchymal Stem Cells (MSCs). Coinfusion of MSCs with hematopoietic stem cells (HSC) improves engraftment and accelerates haematopoietic recovery. Stroma-derived factor-1 (SDF-1) is a chemotactic factor which plays a crucial role in stem cell transplantation by enhancing the ability of HSC to engraft. In this study expression of SDF-1 in bone marrow MSCs and the level of Colony Forming Unit Fibroblast (CFU-F) were evaluated in 8 patients with Acute Myeloid leukemia (AML). Evaluation was done at diagnosis and after induction/consolidation chemotherapy before the onset of haematopoietic stem cell transplantation (HSCT). CFU-F frequency increases from diagnosis to remission. Nevertheless level of stromal derived factor-1 (SDF-1) transcripts in bone marrow MSCs of patients with AML stays low. Considering the role of SDF-1 in the homing of HSC, the consequences of SDF-1 deficiency observed in this study might be deleterious on the engraftment after HSCT and haematopoietic recovery. The whole result of this clinical study is an argument for MSC infusion to restore a normal level of SDF1 in the bone marrow microenvironment that could reduce hematopoietic toxicity of chemotherapy and improve HSC engraftment after HSCT.
- Current pharmaceutical biotechnology.Curr Pharm Biotechnol.2014 Oct;14(9):842-8.
- Bone marrow stroma is damaged by chemotherapy and irradiation protocol. Bone marrow microenvironment supports haematopoiesis and comprises Mesenchymal Stem Cells (MSCs). Coinfusion of MSCs with hematopoietic stem cells (HSC) improves engraftment and accelerates haematopoietic recovery. Stroma-derive
- PMID 24372262
- Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis.
- Stidham RW1, Lee TC, Higgins PD, Deshpande AR, Sussman DA, Singal AG, Elmunzer BJ, Saini SD, Vijan S, Waljee AK.Author information 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, USA.AbstractBACKGROUND: Antibodies against tumour necrosis factor-alpha (anti-TNF) are effective therapies in the treatment of ulcerative colitis (UC), but their comparative efficacy is unknown.
- Alimentary pharmacology & therapeutics.Aliment Pharmacol Ther.2014 Apr;39(7):660-71. doi: 10.1111/apt.12644. Epub 2014 Feb 9.
- BACKGROUND: Antibodies against tumour necrosis factor-alpha (anti-TNF) are effective therapies in the treatment of ulcerative colitis (UC), but their comparative efficacy is unknown.AIM: To perform a network meta-analysis comparing the efficacy of anti-TNF agents in UC.METHODS: After screening 506 s
- PMID 24506179
- Clinical outcome of childhood lymphoblastic lymphoma in Shanghai China 2001-2010.
- Gao YJ1, Pan C, Tang JY, Lu FJ, Chen J, Xue HL, Zhai XW, Li J, Ye QD, Zhou M, Wang HS, Miao H, Qian XW, Xu Z, Meng JH.Author information 1Children's Hospital, Shanghai Medical College, Fudan University, Shanghai, China.AbstractBACKGROUND: This retrospective cohort study analysed the clinical characteristics and outcomes of patients with childhood lymphoblastic lymphoma (LBL) treated in Shanghai, China.
- Pediatric blood & cancer.Pediatr Blood Cancer.2014 Apr;61(4):659-63. doi: 10.1002/pbc.24848. Epub 2013 Nov 14.
- BACKGROUND: This retrospective cohort study analysed the clinical characteristics and outcomes of patients with childhood lymphoblastic lymphoma (LBL) treated in Shanghai, China.PROCEDURE: From 2001 to 2010, 108 evaluable patients ≤16 years of age who were newly diagnosed with biopsy-proven LBL we
- PMID 24243691
Japanese Journal
- 急性骨髄性白血病に対する大量シタラビン療法の意義
- 大竹 茂樹
- 血液内科 67(4), 519-527, 2013-10
- NAID 40019855185
- ガイドライン(標準治療) AMLガイドライン (第75回日本血液学会学術集会 教育講演特集号) -- (骨髄系腫瘍 : AML)
- 宮脇 修一
- 臨床血液 54(10), 1633-1642, 2013-10
- NAID 40019805316
- 高齢者マントル細胞リンパ腫に対する寛解導入療法施行と維持療法に関する第Ⅲ相試験 (特集 血液腫瘍に対する重要な臨床試験と国内外の診療に及ぼすインパクト)
- 岡本 昌隆,稲熊 容子,岡本 晃直
- 血液内科 66(4), 456-463, 2013-04
- NAID 40019688389
Related Links
- 15 Aug 2010 ... The purpose of remission induction chemotherapy is to remove leukemia cells from the bone marrow. Remission is defined as less than 5 percent of leukemia cells remaining in the bone marrow and normal blood counts.
- Remission induction for adults consists of multiagent chemotherapy and injection of chemotherapy into the spinal fluid (intrathecal injection) to prevent relapses in the central nervous system (CNS). Current remission induction therapy involves ...
Related Pictures
★リンクテーブル★
| リンク元 | 「寛解導入療法」「寛解導入」 |
| 関連記事 | 「induction」「remission」 |
「寛解導入療法」
「寛解導入」
「induction」
- n.
- 引き入れること、誘導、導入。(電)誘導。感応、誘発。(発)誘導。(生化)誘導。(医)陣痛/分娩誘発
- 関
- challenge、derivation、elicit、elicitation、guidance、induce、inductive、introduce、introduction、precipitate、provocation、provoke、spark
「remission」
- n.
- (医)寛解